CN113075305A - Method for quantitatively detecting content of lipid-soluble vitamins in peripheral blood sample - Google Patents
Method for quantitatively detecting content of lipid-soluble vitamins in peripheral blood sample Download PDFInfo
- Publication number
- CN113075305A CN113075305A CN202110226116.7A CN202110226116A CN113075305A CN 113075305 A CN113075305 A CN 113075305A CN 202110226116 A CN202110226116 A CN 202110226116A CN 113075305 A CN113075305 A CN 113075305A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- internal standard
- peripheral blood
- sample
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000005259 peripheral blood Anatomy 0.000 title claims abstract description 40
- 239000011886 peripheral blood Substances 0.000 title claims abstract description 40
- 238000000034 method Methods 0.000 title claims abstract description 33
- 229940088594 vitamin Drugs 0.000 title claims description 47
- 239000011782 vitamin Substances 0.000 title claims description 47
- 229930003231 vitamin Natural products 0.000 title claims description 46
- 235000013343 vitamin Nutrition 0.000 title claims description 46
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 52
- 238000001514 detection method Methods 0.000 claims abstract description 49
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 26
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000011709 vitamin E Substances 0.000 claims abstract description 26
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 26
- 229940046009 vitamin E Drugs 0.000 claims abstract description 26
- 229940045997 vitamin a Drugs 0.000 claims abstract description 26
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 24
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 24
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 24
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 24
- 239000011719 vitamin A Substances 0.000 claims abstract description 24
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 24
- 235000005282 vitamin D3 Nutrition 0.000 claims abstract description 23
- 239000011647 vitamin D3 Substances 0.000 claims abstract description 23
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims abstract description 23
- 229940021056 vitamin d3 Drugs 0.000 claims abstract description 23
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229960002061 ergocalciferol Drugs 0.000 claims abstract description 22
- 235000001892 vitamin D2 Nutrition 0.000 claims abstract description 22
- 239000011653 vitamin D2 Substances 0.000 claims abstract description 22
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims abstract description 22
- 239000007788 liquid Substances 0.000 claims abstract description 9
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 8
- 230000006920 protein precipitation Effects 0.000 claims abstract description 8
- 239000006228 supernatant Substances 0.000 claims abstract description 6
- 238000004885 tandem mass spectrometry Methods 0.000 claims abstract 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 30
- 150000002500 ions Chemical class 0.000 claims description 20
- 239000012071 phase Substances 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 150000003863 ammonium salts Chemical class 0.000 claims description 5
- 238000004458 analytical method Methods 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- 238000000065 atmospheric pressure chemical ionisation Methods 0.000 claims description 4
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 3
- 239000005695 Ammonium acetate Substances 0.000 claims description 3
- 235000019257 ammonium acetate Nutrition 0.000 claims description 3
- 229940043376 ammonium acetate Drugs 0.000 claims description 3
- 239000008346 aqueous phase Substances 0.000 claims description 2
- 238000004949 mass spectrometry Methods 0.000 claims description 2
- 239000012074 organic phase Substances 0.000 claims description 2
- 230000011218 segmentation Effects 0.000 claims description 2
- 230000000155 isotopic effect Effects 0.000 claims 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 4
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 claims 1
- 230000001476 alcoholic effect Effects 0.000 claims 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 claims 1
- 238000000132 electrospray ionisation Methods 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 11
- 239000008280 blood Substances 0.000 abstract description 11
- 238000002156 mixing Methods 0.000 abstract description 3
- 238000003260 vortexing Methods 0.000 abstract description 2
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 238000007865 diluting Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 59
- 239000012491 analyte Substances 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 239000011159 matrix material Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000004062 sedimentation Methods 0.000 description 6
- 238000012795 verification Methods 0.000 description 6
- JWUBBDSIWDLEOM-UHFFFAOYSA-N 25-Hydroxycholecalciferol Natural products C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2C1=CC=C1CC(O)CCC1=C JWUBBDSIWDLEOM-UHFFFAOYSA-N 0.000 description 5
- JWUBBDSIWDLEOM-DCHLRESJSA-N 25-Hydroxyvitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C/C=C1\C[C@@H](O)CCC1=C JWUBBDSIWDLEOM-DCHLRESJSA-N 0.000 description 5
- JWUBBDSIWDLEOM-NQZHSCJISA-N 25-hydroxy-3 epi cholecalciferol Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@H](O)CCC1=C JWUBBDSIWDLEOM-NQZHSCJISA-N 0.000 description 5
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 5
- 238000003908 quality control method Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 239000011550 stock solution Substances 0.000 description 5
- JWUBBDSIWDLEOM-XHQRYOPUSA-N (3e)-3-[(2e)-2-[1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol Chemical compound C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2\C1=C\C=C1/CC(O)CCC1=C JWUBBDSIWDLEOM-XHQRYOPUSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 235000021318 Calcifediol Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000001819 mass spectrum Methods 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000000622 liquid--liquid extraction Methods 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000000638 solvent extraction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 238000010811 Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Methods 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000013062 quality control Sample Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- QYSXJUFSXHHAJI-HCXPDEKJSA-N (1s,3z)-3-[(2e)-2-[(1r,3as,7ar)-7a-methyl-1-[(2r)-7,7,7-trideuterio-6-(trideuteriomethyl)heptan-2-yl]-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C([2H])([2H])[2H])C([2H])([2H])[2H])=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-HCXPDEKJSA-N 0.000 description 1
- KJKIIUAXZGLUND-ICCVIKJNSA-N 25-hydroxyvitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](\C=C\[C@H](C)C(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C KJKIIUAXZGLUND-ICCVIKJNSA-N 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000012716 precipitator Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- -1 vitamin a Natural products 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N2030/042—Standards
- G01N2030/045—Standards internal
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
本发明涉及一种定量检测血浆样本中抗病毒药物含量的方法，所述方法包括如下步骤：(1)采集微量末梢血；(2)将末梢血全血样本与含有内标的蛋白沉淀液混合，涡旋后离心，将上清液稀释得到待检测液；(3)采用高效液相色谱串联质谱系统对待检测液进行检测和分析。本发明提供了一种同时检测末梢血样本中维生素A、维生素D2、维生素D3及维生素E的方法，前处理简单，检测成本低，检测效率高。The invention relates to a method for quantitatively detecting the content of antiviral drugs in plasma samples. The method comprises the following steps: (1) collecting a small amount of peripheral blood; (2) mixing the peripheral blood whole blood sample with a protein precipitation solution containing an internal standard, After vortexing, centrifuging, and diluting the supernatant to obtain a liquid to be detected; (3) using a high performance liquid chromatography tandem mass spectrometry system to detect and analyze the liquid to be detected. The invention provides a method for simultaneously detecting vitamin A, vitamin D2, vitamin D3 and vitamin E in peripheral blood samples, with simple pretreatment, low detection cost and high detection efficiency.
Description
Technical Field
The invention relates to the technical field of detection, and mainly relates to a method for quantitatively detecting the content of fat-soluble vitamins in a peripheral blood sample.
Background
The fat-soluble vitamin is a kind of vitamin which is easily dissolved in an organic solvent and is not dissolved in water, and mainly comprises vitamin A, vitamin D, vitamin E and the like. The vitamin can be dissolved in fat, is not easy to be excreted, can be stored in vivo, and plays an important and indispensable role in human metabolism and function. The vitamin A, D, E participates in the synthesis, decomposition and transformation of protein, enzyme, hormone and vitamin in the form of enzyme and prosthetic group activator, respectively, and influences physiological activities such as growth and development, metabolism, immunoregulation, etc. Therefore, it is important to maintain the body's fat-soluble vitamin levels in the appropriate range, and A, D, E deficiency can cause a variety of diseases, while excessive intake can lead to toxicity.
At present, methods for clinically detecting a plurality of fat-soluble vitamins (including vitamin a, vitamin D3, vitamin D2, vitamin E and the like) mainly comprise an immunization method, an electrochemical method, a chromatography method, a liquid chromatography tandem mass spectrometry method and the like, wherein a mainstream fat-soluble vitamin detection sample type is serum, and the amount of blood samples required for detection is relatively large, but because the infants, particularly newborn groups, have the condition of inconvenient blood collection, sufficient serum is difficult to separate for detection. However, fat-soluble vitamin deficiency is a common disease in children, so the fat-soluble vitamin detection item of trace peripheral blood whole blood has a very important meaning, but documents and patents aiming at the fat-soluble vitamin detection of peripheral blood whole blood are few.
CN110488008A and CN 110488004A respectively disclose a kit for detecting 25-hydroxyvitamin D3 in peripheral blood and 25-hydroxyvitamin D in peripheral blood, a preparation method and an application thereof, wherein the two kits respectively comprise a 25-hydroxyvitamin D3 immunochromatographic detection card and a releasing agent, and a 25-hydroxyvitamin D immunochromatographic detection card and a releasing agent, the immunochromatographic detection card comprises a test strip, the test strip comprises a detection line and a quality control line, the detection line is coated with a 25-hydroxyvitamin D3 or a 25-hydroxyvitamin D complete antigen, and the quality control line is coated with a goat anti-rabbit polyclonal antibody. The disadvantage of both methods is that only 25-hydroxyvitamin D3 or 25-hydroxyvitamin D in peripheral blood can be detected, and other types of fat-soluble vitamins cannot be detected.
CN108802221A discloses a trace detection method of vitamin A and vitamin E in peripheral blood, which comprises the following detection steps: 1. adding the peripheral blood sample into a methanol solution containing an internal standard and BHT to complete protein precipitation; 2. adding tert-butyl methyl ether for liquid-liquid extraction, blowing the extracted supernatant with nitrogen at room temperature, adding 80% methanol for redissolution, performing vortex oscillation, and centrifuging to obtain a sample to be detected; 3. detecting by ultra performance liquid chromatography tandem mass spectrometry: and (3) obtaining the peak area of the object to be detected in the sample to be detected and the peak area of the corresponding internal standard through ultra performance liquid chromatography tandem mass spectrometry detection, and completing the detection of vitamin A and vitamin E in the trace peripheral blood sample. CN 110208435a discloses a method for simultaneously detecting the content of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human peripheral blood, which has similar steps to the sample pretreatment and detection steps disclosed in CN108802221A, but uses different types of reagents: 1. adding an ethanol solution containing an internal standard into a peripheral blood sample to perform protein precipitation; 2. adding n-hexane for liquid-liquid extraction, blowing the extracted supernatant with nitrogen at room temperature, adding a methanol-water composite solution containing formic acid, and centrifuging after vortex oscillation to obtain a sample to be detected; 3. and (3) detecting the vitamin D2 and the vitamin D3 in the trace peripheral blood sample by high performance liquid chromatography-tandem mass spectrometry. The two detection methods can only detect the lipid-soluble vitamin D2 and the vitamin D3 in the same batch, and the pretreatment steps are very complicated, time-consuming and labor-consuming, and difficult to realize high-throughput automatic operation.
At present, the type of a common sample for fat-soluble vitamin detection by using liquid chromatography tandem mass spectrometry is serum, the sample size generally needs at least 0.5mL of serum, and the amount of venous blood to be collected is more than 1 mL. For infants, particularly newborns and other people with venipuncture, venous blood of more than 1mL is difficult to collect, so that peripheral blood collection is particularly important. Compared with a serum sample, when fat-soluble vitamin detection is carried out, components such as erythrocytes and the like in a whole blood sample can form a serious matrix effect on the detection of the fat-soluble vitamin, and great difficulty is caused to the development of a whole blood fat-soluble vitamin detection method. In the prior art for detecting soluble vitamins in peripheral blood fat disclosed at present, each scheme can only detect one or two of fat-soluble vitamins, and cannot realize synchronous detection on more than two fat-soluble vitamins. In the prior art for detecting the total blood lipid and vitamin solubility of peripheral blood by using the liquid chromatography-tandem mass spectrometry, the used sample is complicated in pretreatment steps, comprises the steps of protein precipitation, liquid-liquid extraction, drying of extract liquor, redissolving of an object to be detected and the like, is complicated in operation, consumes time and labor, is difficult to realize high-throughput automatic operation, and cannot realize synchronous detection of more than two lipid-soluble vitamins.
Disclosure of Invention
The invention aims to provide a LC-MS detection method which is simple and convenient in pretreatment, high in detection efficiency and low in cost aiming at the defects of the prior art and the clinical detection requirement of peripheral blood fat soluble vitamins, and simultaneously detects vitamin A, vitamin D3, vitamin D2 and vitamin E in peripheral blood. In order to realize the purpose of the invention, the invention provides the following technical scheme:
the invention relates to a method for quantitatively detecting the content of liposoluble vitamin in a peripheral blood sample, wherein the liposoluble vitamin is at least one selected from vitamin A, vitamin D3, vitamin D2 and vitamin E; the method comprises the following steps:
mixing the peripheral blood sample with a protein precipitation solution containing an internal standard, centrifuging after vortexing, and taking supernatant liquid to be tested on a computer;
detecting and analyzing the liquid to be detected by adopting a high performance liquid chromatography-tandem mass spectrometry system;
the protein sedimentation agent containing the internal standard is prepared from an organic solvent and an isotope internal standard, wherein the organic solvent comprises alcohol solvents such as methanol, ethanol and propanol, the isotope internal standard is selected from at least one of a vitamin A isotope internal standard, a vitamin D3 isotope internal standard and a vitamin E isotope internal standard, and the isotope internal standard optionally contains a vitamin D2 isotope internal standard.
Based on the technology, the invention can accurately and efficiently detect the concentrations of vitamin A, vitamin D2, vitamin D3 and vitamin E in a human peripheral blood sample through a simple pretreatment method, and provides a basis for nutrition supplement, clinical diagnosis and treatment.
In a preferred embodiment of the invention, the selected internal standards are vitamin A isotope internal standard, vitamin D3 isotope internal standard and vitamin E isotope internal standard, and the specific forms are vitamin A-D6, vitamin D3-D6 and vitamin E-D6 respectively.
In a preferred embodiment of the present invention, the peripheral blood sample is used in an amount of not more than 50 μ L.
In a preferred embodiment of the present invention, the volume ratio of the peripheral blood sample to be tested to the protein sedimentation agent containing the internal standard is 1:2-1:5, preferably 1: 3. The invention is beneficial to extracting fat-soluble vitamin by reasonably setting the proportion of the two.
In a preferred embodiment of the present invention, the time for analyzing the liquid quality of each peripheral blood sample to be tested does not exceed 5 minutes.
In a preferred embodiment of the present invention, the high performance liquid chromatography conditions are:
the conditions of the high performance liquid chromatography are as follows:
mobile phase A: aqueous phase containing ammonium salt
Mobile phase B: organic phase containing ammonium salt
A chromatographic column: modified C18 chromatographic column
The mobile phase gradient parameters are shown in table 1.
Table 1: high performance liquid chromatography mobile phase gradient
| Time (min) | Flow rate (mL/min) | Mobile phase A (%) | Mobile phase B (%) |
| 0 | 0.7 | 90 | 10 |
| 0.4 | 0.7 | 90 | 10 |
| 1.2 | 0.7 | 25 | 75 |
| 3 | 0.7 | 2 | 98 |
| 4 | 0.7 | 2 | 98 |
| 4.05 | 0.7 | 90 | 10 |
| 4.4 | 0.7 | 90 | 10 |
By adopting the liquid chromatography conditions, the method can effectively separate all lipid-soluble vitamins and control the liquid quality analysis time within 5 minutes.
In a preferred embodiment of the present invention, the mass spectrum conditions of the mass spectrum are:
an ion source: atmospheric pressure chemical ionization source
Mode (2): and positive and negative ion segmentation mode, wherein the detection mode of vitamin E is negative ions, and the detection modes of vitamin D2, vitamin D3 and vitamin A are positive ions.
The mass spectrum condition of the invention can effectively reduce the matrix effect of the complex matrix and ensure the accuracy of the detection result.
In a preferred embodiment of the invention, the method of the invention is for diagnostic purposes or non-diagnostic purposes.
Compared with the prior art, the invention has one or more or all of the following advantages:
(1) the required sample amount is small, and the concentration of vitamin A, vitamin D2, vitamin D3 and vitamin E can be detected by 50uL of peripheral blood samples, so the requirement on the sample amount is low;
(2) according to the invention, the internal standard component and the protein precipitator are prepared together, so that the purposes of protein sedimentation and internal standard correction can be achieved by one-step operation, and the pretreatment process is simplified;
(3) in the pretreatment process, only the sample and the protein sedimentation agent are mixed, vortexed and centrifuged, so that the detection cost is low, the pretreatment time is short, the automatic high-flux sample pretreatment is easy to realize, and the technical requirement on operators is low;
(4) according to the invention, by reasonably setting chromatographic conditions, the liquid quality analysis time of each sample is only 4.4min, and the detection efficiency is high;
(5) in the mass spectrometry condition, the vitamin E is detected in a negative ion mode, so that the complex matrix effect in the peripheral blood sample can be effectively reduced, the matrix interference possibly generated by lipid substances in red blood cells can be effectively reduced, and the accuracy of the detection result can be ensured.
Drawings
FIG. 1 ion extraction chromatograms of vitamin D3 (top panel) and its internal standard (bottom panel);
FIG. 2 ion extraction chromatograms of vitamin D2 (top panel) and its internal standard (bottom panel);
FIG. 3: ion extraction chromatograms of vitamin a (top panel) and its internal standard (bottom panel);
FIG. 4: ion extraction chromatograms of vitamin E (top panel) and its internal standard (bottom panel).
The specific implementation mode is as follows:
the present invention is further illustrated by the following examples, which are intended to be illustrative of the present invention and are not to be construed as limiting the invention, and any modifications and variations of the present invention are intended to fall within the spirit and scope of the appended claims.
Example 1:
(1) configuration of the standard curve: accurately weighed standard substances of vitamin A, vitamin D2, vitamin D3 and vitamin E were dissolved in ethanol to obtain corresponding stock solutions of the standard substances, and then the stock solutions were diluted with PBS to obtain standard curves of the concentrations shown in the following Table 2.
Table 2: concentration of standard curve
| Analyte | Linear range (ng/mL) | SD1 | SD2 | SD3 | SD4 | SD5 | SD6 |
| Vitamin D3 | 5～250 | 5 | 10 | 25 | 50 | 100 | 250 |
| |
2～100 | 2 | 4 | 10 | 20 | 40 | 100 |
| Vitamin A | 40～2000 | 40 | 80 | 200 | 400 | 1000 | 2000 |
| Vitamin E | 500～25000 | 500 | 1000 | 2500 | 5000 | 10000 | 25000 |
(2) Preparation of a protein settling agent: accurately weighed vitamin A-D6, vitamin D3-D6 and vitamin E-D6 are dissolved by ethanol to obtain corresponding isotope internal standard stock solutions, and then the isotope internal standard stock solutions are mixed and diluted by ethanol to form protein sedimentation agent solutions with certain concentrations, as shown in Table 3.
Table 3: concentration of internal standard
| Isotope internal standard | Isotope internal standard concentration (ng/mL) |
| Vitamin D3-D6(VD3-D6) | 10 |
| Vitamin A-d6(VA-d6) | 80 |
| Vitamin E-d6(VE-d6) | 1,000 |
(3) And (3) configuring a standard quality control sample: and (3) uniformly mixing a plurality of peripheral blood whole blood samples to be used as low quality control for detecting the dissolved vitamins in the peripheral blood fat, and accurately adding the standard substance stock solutions with medium concentration and high concentration respectively to obtain medium quality control and high quality control.
(4) Processing of the sample: 50 mu L of standard curve solution, quality control sample and sample to be detected are respectively put into a 96-well plate of 1.2mL, then 150 mu L of protein sedimentation agent is added into each well, and the mixture is centrifuged after being fully vortexed. Taking 100uL of supernatant, and detecting on a computer.
(5) Detection on machine
The conditions of the high performance liquid chromatography are as follows:
mobile phase A: aqueous solution containing ammonium acetate
Mobile phase B: formic acid solution containing ammonium acetate
A chromatographic column: modified C18 chromatographic column
The mobile phase gradient parameters are shown in table 4.
Table 4: high performance liquid chromatography mobile phase gradient
| Time (min) | Flow rate (mL/min) | Mobile phase A (%) | Mobile phase B (%) |
| 0 | 0.7 | 90 | 10 |
| 0.4 | 0.7 | 90 | 10 |
| 1.2 | 0.7 | 25 | 75 |
| 3 | 0.7 | 2 | 98 |
| 4 | 0.7 | 2 | 98 |
| 4.05 | 0.7 | 90 | 10 |
| 4.4 | 0.7 | 90 | 10 |
The mass spectrum conditions are as follows:
an ion source: APCI (APCI is an atmospheric pressure chemical ionization source, the sample is first formed into a mist, then a corona discharge discharges against it, in a high voltage arc, the sample is ionized, then desolvated to form ions, and finally detected.)
Mode (2): positive and negative ion segment mode (positive and negative ion detection segment time: 3.3 minutes)
The mass spectrometric detection parameters are shown in table 5.
Table 5: mass spectrometric detection parameters
Note: the analytes-1 are all quantitative ion pairs, and the analyte-2 is a qualitative ion pair.
The retention times of the compounds are shown in table 6.
Table 6: fat soluble vitamin retention time
| Name of Compound | Retention time (min) |
| Vitamin D3 | 2.75 |
| Vitamin D2 | 2.81 |
| Vitamin A | 2.82 |
| Vitamin E | 3.86 |
(6) Data processing
Data were collected using Sciex Analyst software and processed using multisquant software. And (3) performing linear least square regression calculation on the theoretical concentration of the analyte in the standard curve by comparing the peak area of the analyte with the peak area of the internal standard, and calculating the actually measured concentration of the analyte in the sample by using the obtained regression equation. The measured concentration of the analyte in the sample is calculated from the following regression equation:
y＝ax+b
where y is the peak area ratio of analyte to internal standard
b is intercept
a slope of
x is the concentration of the analyte
The results are shown in Table 7.
Table 7: the result of the detection
| Vitamin A (ng/mL) | Vitamin D2(ng/mL) | Vitamin VD3(ng/mL) | Vitamin E (ng/mL) | |
| |
456.12 | 2.18 | 7.05 | 5891.11 |
| |
415.75 | 1.81 | 7.48 | 7234.35 |
| |
370.63 | 2.01 | 5.42 | 5276.21 |
| Sample 4 | 441.25 | 1.27 | 7.93 | 6936.17 |
| Sample 5 | 640.14 | 1.13 | 11.77 | 10100.58 |
| |
373.06 | 1.35 | 5.43 | 4398.84 |
| |
433.19 | 1.49 | 8.77 | 5293.34 |
| |
564.55 | 1.42 | 8.39 | 6224.19 |
| Sample 9 | 493.69 | 1.17 | 8.2 | 5257.36 |
| Sample 10 | 342.22 | 1.84 | 7.85 | 5333 |
| Sample 11 | 588.98 | 2.87 | 7.74 | 8920.18 |
| Sample 12 | 386.48 | 1.76 | 14.32 | 6660.46 |
| Sample 13 | 578.9 | 1.83 | 9.71 | 5226.35 |
| Sample 14 | 361.62 | 1.52 | 7.65 | 7927.09 |
| Sample 15 | 460.67 | 1.14 | 21.86 | 7359.72 |
| Sample 16 | 387.38 | 1.19 | 7.72 | 4695.4 |
| Sample 17 | 474.81 | 1.79 | 6.6 | 4637.85 |
| Sample 18 | 397.49 | 1.49 | 21.51 | 7453.07 |
| Sample 19 | 531.34 | 1.09 | 12.97 | 7578.74 |
| Sample 20 | 551.5 | 1.07 | 4.97 | 6165.21 |
According to the analysis of the results of the above examples, the present invention can simultaneously detect vitamin A, vitamin D2, vitamin D3 and vitamin E in peripheral blood samples. The method has simple sample pretreatment and is easy to carry out automatic high-flux sample treatment; only 50uL of peripheral blood samples are needed in each detection, and the kit is particularly suitable for infant groups with nutrition detection requirements and blood sampling difficulty; the liquid quality analysis time is only 4.5min, and the detection efficiency is high; the detection mode of the vitamin E is negative ions, so that the matrix effect of a complex matrix can be effectively reduced, and the accuracy of a detection result is ensured. Therefore, the invention provides a method for simultaneously detecting vitamin A, vitamin D2, vitamin D3 and vitamin E in a peripheral blood sample, and the method has the advantages of simple pretreatment, low detection cost and high detection efficiency.
The fat-soluble vitamins in the examples were subjected to a methodological validation test. The accuracy of the methodology of the present invention is determined by performing a standard recovery experiment on clinical samples, the precision of the methodology of the present invention is determined by day precision experiments, the spectrograms of each analyte and its internal standard are shown in fig. 1-4, and it can be known from the results of the spectrograms that the method of the present invention can well separate each lipo-vitamin. The results of verifying the accuracy and precision of each analyte are shown in tables 8-11 below.
Table 8: verification of accuracy and precision of vitamin D3
Table 9: verification of accuracy and precision of vitamin D2
Table 10: verification of accuracy and precision of vitamin A
Table 11: verification of accuracy and precision of vitamin E
The verification result shows that the technical scheme of the invention can simultaneously detect a plurality of fat-soluble vitamins in peripheral blood, including vitamin A, vitamin D3, vitamin D2 and vitamin E. The method has simple sample pretreatment, and only needs to add the protein settling agent and then carry out vortex centrifugation; the result has high accuracy and good precision, and the coefficient of variation (CV%) of each analyte is less than 15%; the deviation (bias) of the recovery rate of each analyte in the standard sample is less than 15 percent, and the method meets the verification requirement.
The foregoing describes preferred embodiments of the present invention, but is not intended to limit the invention thereto. Modifications and variations of the embodiments disclosed herein may be made by those skilled in the art without departing from the scope and spirit of the invention.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110226116.7A CN113075305A (en) | 2021-03-01 | 2021-03-01 | Method for quantitatively detecting content of lipid-soluble vitamins in peripheral blood sample |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110226116.7A CN113075305A (en) | 2021-03-01 | 2021-03-01 | Method for quantitatively detecting content of lipid-soluble vitamins in peripheral blood sample |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113075305A true CN113075305A (en) | 2021-07-06 |
Family
ID=76609704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110226116.7A Pending CN113075305A (en) | 2021-03-01 | 2021-03-01 | Method for quantitatively detecting content of lipid-soluble vitamins in peripheral blood sample |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113075305A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114280177A (en) * | 2021-12-15 | 2022-04-05 | 上海市徐汇区中心医院 | Detection method of fat-soluble vitamin A, D, E |
| CN114527230A (en) * | 2022-02-28 | 2022-05-24 | 上海药明奥测医疗科技有限公司 | Method for detecting concentration of vitamin A and vitamin E in human dry blood spots |
| CN115165854A (en) * | 2022-07-09 | 2022-10-11 | 郑州爱微迪医学检验实验室有限公司 | A method for detecting peripheral blood |
| CN115656381A (en) * | 2022-11-10 | 2023-01-31 | 成都新基因格医学检验所有限公司 | Quantitative detection method for fat-soluble vitamin D of small-volume sample |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106645500A (en) * | 2017-02-23 | 2017-05-10 | 广州市丰华生物工程有限公司 | Method and kit for detecting various vitamins in serum/plasma at same time |
| CN108802221A (en) * | 2018-06-12 | 2018-11-13 | 杭州度安医学检验实验室有限公司 | The Sparklet testing method of vitamin A and vitamin E in peripheral blood |
| CN110208438A (en) * | 2019-07-12 | 2019-09-06 | 北京和合医学诊断技术股份有限公司 | Method that is a kind of while detecting a variety of liposoluble vitamin contents in blood |
| CN110208435A (en) * | 2019-07-12 | 2019-09-06 | 北京和合医学诊断技术股份有限公司 | The method for detecting 25-hydroxyvitamin D3 and 25-OH Vintamin D2 content in people's peripheral blood simultaneously |
| CN110542735A (en) * | 2019-09-12 | 2019-12-06 | 贝知(上海)医疗科技有限公司 | method for high-throughput determination of multiple fat-soluble vitamins by ultra-high performance liquid mass spectrometry |
| CN110967424A (en) * | 2019-12-05 | 2020-04-07 | 贾广阔 | Liquid phase-mass spectrum combined detection method for fat-soluble vitamins in serum |
| CN111208248A (en) * | 2020-01-14 | 2020-05-29 | 南京品生医学检验实验室有限公司 | Method for detecting 5 fat-soluble vitamins in serum by ultra-high performance liquid chromatography tandem mass spectrometry |
| US20200249227A1 (en) * | 2019-01-31 | 2020-08-06 | Alcala Pharmaceutical, Inc. | Method for detecting and quantifying vitamins and thyroid analytes from a urine sample |
| CN111999397A (en) * | 2020-07-07 | 2020-11-27 | 大连和合医学检验实验室有限公司 | Method for simultaneously detecting multiple fat-soluble vitamins |
-
2021
- 2021-03-01 CN CN202110226116.7A patent/CN113075305A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106645500A (en) * | 2017-02-23 | 2017-05-10 | 广州市丰华生物工程有限公司 | Method and kit for detecting various vitamins in serum/plasma at same time |
| CN108802221A (en) * | 2018-06-12 | 2018-11-13 | 杭州度安医学检验实验室有限公司 | The Sparklet testing method of vitamin A and vitamin E in peripheral blood |
| US20200249227A1 (en) * | 2019-01-31 | 2020-08-06 | Alcala Pharmaceutical, Inc. | Method for detecting and quantifying vitamins and thyroid analytes from a urine sample |
| CN110208438A (en) * | 2019-07-12 | 2019-09-06 | 北京和合医学诊断技术股份有限公司 | Method that is a kind of while detecting a variety of liposoluble vitamin contents in blood |
| CN110208435A (en) * | 2019-07-12 | 2019-09-06 | 北京和合医学诊断技术股份有限公司 | The method for detecting 25-hydroxyvitamin D3 and 25-OH Vintamin D2 content in people's peripheral blood simultaneously |
| CN110542735A (en) * | 2019-09-12 | 2019-12-06 | 贝知(上海)医疗科技有限公司 | method for high-throughput determination of multiple fat-soluble vitamins by ultra-high performance liquid mass spectrometry |
| CN110967424A (en) * | 2019-12-05 | 2020-04-07 | 贾广阔 | Liquid phase-mass spectrum combined detection method for fat-soluble vitamins in serum |
| CN111208248A (en) * | 2020-01-14 | 2020-05-29 | 南京品生医学检验实验室有限公司 | Method for detecting 5 fat-soluble vitamins in serum by ultra-high performance liquid chromatography tandem mass spectrometry |
| CN111999397A (en) * | 2020-07-07 | 2020-11-27 | 大连和合医学检验实验室有限公司 | Method for simultaneously detecting multiple fat-soluble vitamins |
Non-Patent Citations (3)
| Title |
|---|
| SVETLANA A. LANINA ET AL.: "Comparison of reversed-phase liquid chromatography-mass spectrometry with electrospray and atmospheric pressure chemical ionization for analysis of dietary tocopherols", 《JOURNAL OF CHROMATOGRAPHY A》 * |
| YOLANDA PICO, 中国轻工业出版社 * |
| 李金蓉 等: "液质联用定量血清中维生素D、A、E的方法", 《国际检验医学杂志》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114280177A (en) * | 2021-12-15 | 2022-04-05 | 上海市徐汇区中心医院 | Detection method of fat-soluble vitamin A, D, E |
| CN114527230A (en) * | 2022-02-28 | 2022-05-24 | 上海药明奥测医疗科技有限公司 | Method for detecting concentration of vitamin A and vitamin E in human dry blood spots |
| CN115165854A (en) * | 2022-07-09 | 2022-10-11 | 郑州爱微迪医学检验实验室有限公司 | A method for detecting peripheral blood |
| CN115656381A (en) * | 2022-11-10 | 2023-01-31 | 成都新基因格医学检验所有限公司 | Quantitative detection method for fat-soluble vitamin D of small-volume sample |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113075305A (en) | Method for quantitatively detecting content of lipid-soluble vitamins in peripheral blood sample | |
| CN105158394B (en) | A kind of method simultaneously detecting multiple liposoluble vitamin in blood sample | |
| CN105424854B (en) | A kind of method of multiple water-soluble vitamin in blood sample of detection simultaneously | |
| CN110057955B (en) | Method for screening specific serum marker of hepatitis B | |
| CN110542735A (en) | method for high-throughput determination of multiple fat-soluble vitamins by ultra-high performance liquid mass spectrometry | |
| CN111175405A (en) | Method for simultaneously detecting multiple fat-soluble vitamins in blood sample and application thereof | |
| CN112834677A (en) | Method for simultaneously detecting homocysteine and metabolic related substances thereof | |
| CN104991019B (en) | Gelsemine and the liquid chromatography-tandem mass of koumine in biological material | |
| CN104914176A (en) | Method for quantitatively analyzing retinol and precursor thereof on dry blood spot card with tiny amount of blood | |
| CN113390978A (en) | Analysis method for determining content of free testosterone in human serum sample by equilibrium dialysis and LC-MS/MS technology | |
| CN113125601B (en) | Method for simultaneously detecting concentrations of 4 fat-soluble vitamins in serum | |
| CN113552229A (en) | Vitamin K in serum1High performance liquid chromatography tandem mass spectrometry detection method | |
| CN110057954B (en) | Application of plasma metabolic markers in diagnosis or monitoring of HBV | |
| US20200249227A1 (en) | Method for detecting and quantifying vitamins and thyroid analytes from a urine sample | |
| CN112505179B (en) | Method for measuring isotope dilution ultra-performance liquid chromatography-mass spectrometry combination | |
| CN114509509A (en) | Method for detecting full-spectrum vitamins in serum | |
| CN115902048A (en) | Method for detecting water-soluble vitamins in serum by methyl derivatization-high performance liquid chromatography tandem mass spectrometry | |
| CN114755323A (en) | Detection method and kit for fat-soluble vitamin content in dried blood paper slices | |
| CN111458417A (en) | Method and kit for combined detection of multiple antibiotics in sample to be detected | |
| CN117147712A (en) | A liquid chromatography mass spectrometry analysis method for detecting 11 types of vitamin D in blood | |
| CN114280178B (en) | Detection method for multiple water-soluble vitamins | |
| CN114487246B (en) | Lipid metabolism marker composition for detecting acute myocardial infarction, kit and application | |
| CN118150669A (en) | Metabolite qualitative method based on direct sample injection mass spectrum | |
| Wang et al. | Advancing towards practice: A novel LC-MS/MS method for detecting retinol in dried blood spots | |
| CN111198235B (en) | A kind of detection method of isoflavone content in plasma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 310000 room 701-6, building 2, Zijin Qizhen building, No. 859 Shixiang West Road, Sandun Town, Xihu District, Hangzhou City, Zhejiang Province Applicant after: Kailaipu Technology Co.,Ltd. Address before: Room 701-6, building 2, Zijin Qizhen building, 859 Shixiang West Road, Sandun Town, Xihu District, Hangzhou City, Zhejiang Province, 310030 Applicant before: HANGZHOU CALIBRA DIAGNOSTICS CO.,LTD. |
|
| CB02 | Change of applicant information |